Author(s):
Elizabeth N. Xavier, Jashna K. Kani
Email(s):
jashna92@gmail.com
DOI:
10.5958/0974-360X.2021.00089.5 
Address:
Elizabeth N. Xavier1, Jashna K. Kani2
1Assistant Professor, Department of Pharmaceutics, Nirmala College of Pharmacy, Muvattupuzha, Ernakulam (Dist), Kerala, 686661.
2Student, M Pharm Pharmaceutics, Nirmala College of Pharmacy, Muvattupuzha, Ernakulam (Dist), Kerala, 686661.
*Corresponding Author
Published In:
Volume - 14,
Issue - 1,
Year - 2021
ABSTRACT:
Embelia ribes or black pepper contains many bioactive constituents of pharmaceutical importance. It contains alkaloids, tannins, fixed oils, and traces of volatile oils and benzoquinone derivative Embelin. Embelin (2,5- dihydroxy 3-undecyl, 1, 4-benzoquinone), a benzoquinone derivative has reported to have anticancer, anti-inflammatory, antimicrobial, anti-diabetic, wound healing, antioxidant, analgesic, antitumor and anthelmintic activities. Due to poor aqueous solubility, bioavailability its therapeutic potential is not fully utilized. This review summarises recent literature on biological, analytical and formulative aspects of EMB. Proposed mechanisms for various bioactivities of EMB are brought under limelight. UV double beam spectrophotometry, thin layer chromatography, high performance liquid chromatography (HPLC) and HPTLC techniques for EMB quantification are discussed. Types of dosage forms and its potential for controlled and targeted delivery of EMB are also discussed. This review will open the ways for development of an optimum formulation of EMB for its reported biological activities.
Cite this article:
Elizabeth N. Xavier, Jashna K. Kani. Bioactivity, Analytical Techniques and Formulative approaches for Embelin. Research J. Pharm. and Tech. 2021; 14(1):487-492. doi: 10.5958/0974-360X.2021.00089.5
Cite(Electronic):
Elizabeth N. Xavier, Jashna K. Kani. Bioactivity, Analytical Techniques and Formulative approaches for Embelin. Research J. Pharm. and Tech. 2021; 14(1):487-492. doi: 10.5958/0974-360X.2021.00089.5 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-1-89
REFERENCES:
1. Kunnumakkara AB, Sailo BL, Banik K, Harsha C, Prasad S, Gupta SC, Bharti AC, Aggarwal BB. Chronic diseases, inflammation, and spices: how are they linked?. Journal of translational medicine. 2018 Dec;16(1):14.
2. Li Z, Chen SJ, Yu XA, Li J, Gao XM, He J, Chang YX. Pharmacokinetic And Bioavailability Studies Of Embelin After Intravenous And Oral Administration To Rats. Evidence-Based Complementary And Alternative Medicine. 2019;2019.
3. Kocak C, Kocak FE, Akcilar R, Isiklar OO, Kocak H, Bayat Z, Simsek H, Taser F, Altuntas I. Molecular and biochemical evidence on the protective effects of embelin and carnosic acid in isoproterenol-induced acute myocardial injury in rats. Life sciences. 2016 Feb 15;147:15-23.
4. Asadulla S, Ramandang R. Pharmacognosy of Embelia ribes Burm f. Int J Res Pharm Chem. 2011;1(4):1236-51.
5. Agrawal S, Chauhan S, Mathur R. Antifertility effects of embelin in male rats. Andrologia. 1986 Mar 4;18(2):125-31.
6. Kumar K, Dhamotharan R, Kulkarni NM, Honnegowda S, Murugesan S. Embelin ameliorates dextran sodium sulfate-induced colitis in mice. International immunopharmacology. 2011 Jun 1;11(6):724-31.
7. Mahendran S, Badami S, Maithili V. Evaluation of antidiabetic effect of embelin from Embelia ribes in alloxan induced diabetes in rats. Biomedicine & Preventive Nutrition. 2011 Jan 1;1(1):25-31.
8. Durg S, Veerapur VP, Neelima S, Dhadde SB. Antidiabetic activity of Embelia ribes, embelin and its derivatives: A systematic review and meta-analysis. Biomedicine & Pharmacotherapy. 2017 Feb 1;86:195-204.
9. Sahu BD, Anubolu H, Koneru M, Kumar JM, Kuncha M, Rachamalla SS, Sistla R. Cardioprotective effect of embelin on isoproterenol-induced myocardial injury in rats: possible involvement of mitochondrial dysfunction and apoptosis. Life sciences. 2014 Jun 27;107(1-2):59-67.
10. Mahendran S, Thippeswamy BS, Veerapur VP, Badami S. Anticonvulsant activity of embelin isolated from Embelia ribes. Phytomedicine. 2011 Jan 15;18(2-3):186-8.
11. Afzal M, Gupta G, Kazmi I, Rahman M, Upadhyay G, Ahmad K, Imam F, Pravez M, Anwar F. Evaluation of anxiolytic activity of embelin isolated from Embelia ribes. Biomedicine & Aging Pathology. 2012 Apr 1;2(2):45-7.
12. Feresin GE, Tapia A, Sortino M, Zacchino S, de Arias AR, Inchausti A, Yaluff G, Rodriguez J, Theoduloz C, Schmeda-Hirschmann G. Bioactive alkyl phenols and embelin from Oxalis erythrorhiza. Journal of ethnopharmacology. 2003 Oct 1;88(2-3):241-7.
13. Lal B, Mishra N. Importance of Embelia ribes: An update. International Journal of Pharmaceutical Sciences and Research. 2013 Oct 1;4(10):3823.
14. Shuveksh PS, Ahmed K, Padhye S, Schobert R, Biersack B. Chemical and biological aspects of the natural 1, 4-benzoquinone embelin and its (semi-) synthetic derivatives. Current medicinal chemistry. 2017 Jun 1;24(18):1998-2009.
15. Souravi K, Rajasekharan Pe. Ethnopharmacological Uses Of Embelia Ribes Burm. F. A Review. Iosr Journal Of Pharmacy And Biological Sciences. 2014;9(3):23-30.
16. Poojari R. Embelin–a drug of antiquity: shifting the paradigm towards modern medicine. Expert opinion on investigational drugs. 2014 Mar 1;23(3):427-44.
17. Rani VU, Jyothi G, Rao GN, Sailaja BB. Chemical speciation of binary complexes of embelin with some biologically important metal ions. Acta Chimica Slovenica. 2010 Dec 1;57(4).
18. Ko JH, Lee SG, Yang WM, Um JY, Sethi G, Mishra S, Shanmugam MK, Ahn KS. The application of embelin for cancer prevention and therapy. Molecules. 2018 Mar;23(3):621.
19. Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, Lippman ME. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. Journal of medicinal chemistry. 2004 May 6;47(10):2430-40.
20. Park N, Baek HS, Chun YJ. Embelin-induced apoptosis of human prostate cancer cells is mediated through modulation of Akt and β-Catenin signaling. PloS one. 2015;10(8).
21. Dai Y, DeSano J, Qu Y, Tang W, Meng Y, Lawrence TS, Xu L. Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer. American journal of cancer research. 2011;1(2):128.
22. Nigam N, Grover A, Goyal S, Katiyar SP, Bhargava P, Wang PC, Sundar D, Kaul SC, Wadhwa R. Targeting mortalin by embelin causes activation of tumor suppressor p53 and deactivation of metastatic signaling in human breast cancer cells. PLoS One. 2015;10(9).
23. Rezkita F, Wibawa KG, Nugraha AP. Curcumin loaded Chitosan Nanoparticle for Accelerating the Post Extraction Wound Healing in Diabetes Mellitus Patient: A Review. Research Journal of Pharmacy and Technology. 2020 Feb 15;13(2):1039-42
24. Swamy HK, Krishna V, Shankarmurthy K, Rahiman BA, Mankani KL, Mahadevan KM, Harish BG, Naika HR. Wound healing activity of embelin isolated from the ethanol extract of leaves of Embelia ribes Burm. Journal of ethnopharmacology. 2007 Feb 12;109(3):529-34.
25. Bhandari U, Jain N, Pillai KK. Further studies on antioxidant potential and protection of pancreatic β-cells by Embelia ribes in Experimental diabetes. Journal of Diabetes Research. 2007;2007.
26. Radhakrishnan N, Gnanamani A, Mandal AB. A potential antibacterial agent Embelin, a natural benzoquinone extracted from Embelia ribes. Biology and medicine. 2011;3(2):1-7.
27. Rondevaldova J, Leuner O, Teka A, Lulekal E, Havlik J, Van Damme P, Kokoska L. In vitro antistaphylococcal effects of Embelia schimperi extracts and their component embelin with oxacillin and tetracycline. Evidence-Based Complementary and Alternative Medicine. 2015;2015.
28. Thyloor R. Phytochemical analysis of Embelia ribes seeds for antimicrobial activities. Journal of Medicinal Plants. 2018;6(4):41-3.
29. Kundap UP, Bhuvanendran S, Kumari Y, Othman I, Shaikh M. Plant derived phytocompound, embelin in CNS disorders: a systematic review. Frontiers in pharmacology. 2017 Feb 27;8:76.
30. Prathyusha P, Sundararajan R. UV spectrophotometric method for determination of Bilastine in bulk and pharmaceutical formulation. Research Journal of Pharmacy and Technology. 2020 Feb 15;13(2):933-8.
31. Thoddi P, Gautam GK, BH CN. Stability indicating validated RP-HPLC method for Simultaneous estimation of Elbasvir and Grazopravir in Bulk and Pharmaceutical Dosage form. Research Journal of Pharmacy and Technology. 2020 Feb 15;13(2):950-5.
32. Chauhan SK, Singh BP, Agarwal S. A TLC identification and spectrophotometric estimation of embelin in Embelia ribes. Ancient science of life. 1999 Jul;19(1-2):46.
33. Rastogi S, Bhatia AK, Kushwaha A, Pandey MK, Sharma A, Prakash J, Singh GN. Development and validation of a liquid chromatography method for determination of embelin in crude extract of Embelia ribes. Asian Journal of Biomedical and Pharmaceutical Sciences. 2014 Sep 1;4(36):9.
34. Patel RK, Patel VR, Patel MG. Development and validation of a RP-HPLC method for the simultaneous determination of Embelin, Rottlerin and Ellagic acid in Vidangadi churna. Journal of pharmaceutical analysis. 2012 Oct 1;2(5):366-71.
35. Alam MS, Damanhouri ZA, Ahmad A, Abidin L, Amir M, Aqil M, Khan SA, Mujeeb M. Development of response surface methodology for optimization of extraction parameters and quantitative estimation of embelin from Embelia ribes Burm by high performance liquid chromatography. Pharmacognosy magazine. 2015 May;11(Suppl 1):S166.
36. Shelar R, Maurya C, Tekale P, Katkar K, Naik V, Suthar A, Chauhan VS. Embelin-An HPLC method for quantitative estimation in Embelia ribes Burm. F. Int J Pharm Clin Res. 2009;1:146-9.
37. Swami D, Fulzele D, Malpathak N. Identification and Quantification of Embelin by Validated HPTLC Method and Confirmation by LC-MS from Mangrove Plant Aegiceras corniculatum L. Journal of Chemical and Pharmaceutical Research. 2017;9(1):168-73.
38. Madhavan SN, Arimboor R, Arumughan C. RP‐HPLC‐DAD method for the estimation of embelin as marker in Embelia ribes and its polyherbal formulations. Biomedical chromatography. 2011 May;25(5):600-5.
39. Prasad SB, Bist M, Verma SP. Development and validation of the UV-spectrophotometric method for determination of embelin. Int J Pharm Quality Assurance. 2016 Aug 22;7(3):51-4.
40. Singh AK, Singh A. Phyto-Phospholipid Complexes: A Potential Novel Carrier System for Improving Bioavailability of Phytoconstituents. Research Journal of Pharmacy and Technology. 2020 Feb 15;13(2):1059-66.
41. Mohanrao BM, Sundar PS, Nagsen S. Oral bioavailability enhancement of a poor water soluble drug by cosurfactant free self-emulsifying drug delivery system (SEDDS). Research Journal of Pharmacy and Technology. 2011;4(10):1557-62
42. Akiladevi D, Prakash H, Gb B, Madumitha N. Nano-novel approach: Self Nano Emulsifying Drug Delivery System (SNEDDS)-Review Article. Research Journal of Pharmacy and Technology. 2020 Feb 15;13(2):983-90.
43. Prabhakar C, Krishna KB. A Review on Polymeric Nanoparticles. Research Journal of Pharmacy and Technology. 2011;4(4):496-8
44. Pradeep NS. A Review: Increasing Solubility of Poorly Soluble Drugs, by Solid Dispersion Technique. Research Journal of Pharmacy and Technology. 2011;4(12):1933-40.
45. Asija R, Patel P, Asija S. The Liquisolid Technique for Enhancement of Drug Dissolution. Research Journal of Pharmacy and Technology. 2012;5(10):1270-4.
46. Vyas A, Gidwani B. Technologies to counter poor solubility issues: A review. Research Journal of Pharmacy and Technology. 2013;6(11):1258-70.
47. Nidhi, Dadwal A, Hallan SS, Sharma S, Mishra N. Development of enteric-coated microspheres of embelin for their beneficial pharmacological potential in ulcerative colitis. Artificial cells, nanomedicine, and biotechnology. 2017 Aug 18;45(6):1092-100.
48. Tornello PR, Feresin GE, Tapia A, Veiga IG, Moraes ÂM, Abraham GA, Cuadrado TR. Dispersion and release of embelin from electrospun, biodegradable, polymeric membranes. Polymer journal. 2012 Nov;44(11):1105-11.
49. Rashid M, Wani TU, Mishra N, Sofi HS, Ashraf R, Sheikh FA. Development and characterization of drug-loaded self-solid nano-emulsified drug delivery system for treatment of diabetes. Material Science Research India. 2018 Apr 20;15(1):01-11.
50. Badamaranahalli SS, Kopparam M, Bhagawati ST, Durg S. Embelin lipid nanospheres for enhanced treatment of ulcerative colitis–Preparation, characterization and in vivo evaluation. European journal of pharmaceutical sciences. 2015 Aug 30;76:73-82.
51. Parmar K, Patel J, Sheth N. Formulation and development of embelin liquisolid systems using quality by design approach. Journal of Pharmaceutical Investigation. 2016 Oct 1;46(6):547-56.
52. Sharma A, Kaur N, Sharma S, Sharma A, Rathore MS, Ajay K, Mishra N. Embelin-loaded guar gum microparticles for the management of ulcerative colitis. Journal of microencapsulation. 2018 Feb 17;35(2):181-91.
53. Jain S, Jain N. PUB040 Formulation and Evaluation of Embelin Loaded Transfersome for Effective Treatment of Skin Cancer. Journal of Thoracic Oncology. 2017 Nov 1;12(11):S2378.
54. Pathan RA, Bhandari U. Preparation & characterization of embelin–phospholipid complex as effective drug delivery tool. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2011 Feb 1;69(1-2):139-47.
55. Alam MS, Ahad A, Abidin L, Aqil M, Mir SR, Mujeeb M. Embelin-loaded oral niosomes ameliorate streptozotocin-induced diabetes in Wistar rats. Biomedicine & Pharmacotherapy. 2018 Jan 1;97:1514-20.
56. Nidhi NM. Eudragit Coated Microspheres of Embelin for Treatment of Ulcerative Colitis. Ann Pharmacol Pharm. 2017; 2 (14).;1076.
57. Sekar M. Formulation and evaluation of embelin emulgel for topical delivery. International Journal of Green Pharmacy (IJGP). 2019 Mar 9;13(01).
58. Parmar K, Patel J, Sheth N. Self nano-emulsifying drug delivery system for Embelin: Design, characterization and in-vitro studies. asian journal of pharmaceutical sciences. 2015 Oct 1;10(5):396-404.
59. Patel R, Pundarikakshudu K, Momin M, Patel M. Studies On Formulation And Studies On Formulation And In Vitro Dissolution Of Dissolution Of Embelin T Embelin Tablets. Indian Journal Of Pharmaceutical Sciences. 2006 Mar:228.
60. Sharma N, Bhandari S, Deshmukh R, Yadav AK, Mishra N. Development and characterization of embelin-loaded nanolipid carriers for brain targeting. Artificial cells, nanomedicine, and biotechnology. 2017 Apr 3;45(3):409-13.
61. Gadhave MV, Banerjee SK. Preparation and Characterization of Spherical Crystals of Embelin to Improve the Solubility and Micromeritic Properties. Int. J. Pharm. Clin. Res. 2014;6:363-9.
62. Neeraj, Mittal V, Nanda A. Development And In Vitro Evaluation Of Self Emulsifying Formulation For Embelin. International Journal Of Pharmaceutical Sciences And Research. 2018 Feb 1;9(2):633-41.
63. Shrotriya SN, Chidrawar KR, Nagras MA, Mulgund SV. Solubility Enhancement Studies Of Embelin By Solid Dispersion Technique. Inventi Rapid: Pharm Tech. 2012 Jan 7.
64. Parmar K, Patel J, Sheth N. Self nano-emulsifying drug delivery system for Embelin: Design, characterization and in-vitro studies. asian journal of pharmaceutical sciences. 2015 Oct 1;10(5):396-404.